[1]
2022. Blood levels of circulating tumor cells and factors of growth and progression in patients with locally advanced triple negative breast cancer receiving neoadjuvant chemotherapy. Voprosy onkologii. 68, 3 (Jul. 2022), 362–366. DOI:https://doi.org/10.37469/0507-3758-2022-68-3-362-366.